
Achieving patient-centricity under the new MDR - balancing stakeholder interests
​
22-23 October 2020 | Virtual Annual Conference
MPP2020 Program Day 1
Morning
09:00
Conference opening and welcome address
Shayesteh Fürst Ladani, SFL, President MPP Association
​
Welcome address
Karin Sartorius, Manager Life Sciences, Economic development, Office of Economy and Labour, Canton of Basel-Stadt
MPP2020 Program Committee Chair’s introduction
Daniel Diezi, Gerresheimer
09:30
Keynote address
Zaïde Frias, Head of the Digital Business Transformation Task Force, European Medicines
Agency (EMA)
10:15
Break & 1-on-1 partnering powered by Zühlke
10:45
Session 1 - New and emerging technologies
Chair: Michel Dard, Straumann
​
Data-driven business models – delivering value in the pharma & healthcare IoT
Daniel Weber, Detecon
Point-of-care transformation: bringing personalized care to the home setting
Frederik Mortier, Verhaert
Devices for drug delivery to the brain
Nico Stohler, Roche
Afternoon
13:30
Session 2 - Panel discussion on the Medical Devices Regulation and Combined Products
Chair: Shayesteh Fürst Ladani, SFL, President MPP Association
​
Erik Hansson, DG SANTE, European Commission
llona Reischl, Austrian Agency for Health and Food Safety – Austrian Medicines and Medical Devices Agency (AGES-MEA)
Serge Mathonet, Sanofi, EFPIA
Julia Frese, TÜV SÜD
Merlin Rietschel, Medtech Europe
Stephan Affolter, Ypsomed, MPP Board
15:00
Break & 1-on-1 partnering powered by Zühlke
15:30
Session 3 - From ideation to innovative products
Chair: Karin Schulze, SFL
​
Smart data in the service of patient safety
Goranka Tanackovic Abbas-Terki, Gene Predictis
Automated production of artificial personalized skin - A closed system for process automation
Daniela Marino, Cutiss & Reto Frei, Zühlke
Patenting strategies for startups, spinoffs and other projects based on patentable innovations at early stages
Christoph Klöckner, Winter, Brandl, Fürniss, Hübner, Röss, Kaiser, Polte – Partnerschaft
MPP2020 Program Day 2
Morning
08:45
Conference opening
Daniel Delfosse, Head Regulatory Affairs, Swiss Medtech, MPP Board
09:00
Session 4 - Innovation for successful development of healthcare products
Chair: Andy Tonazzi, Konplan systemhaus ag
​
Using modeling and simulation in the design of closed-loop medical devices
Sébastien Dupertuis, MathWorks
Using platforms to reduce the time and effort to bring new drug delivery combination products to the market
Christoph Muenzer, Novartis
Moore4Medical: towards open technology platforms for medical devices
Ronald Dekker, Philips
10:30
Break & 1-on-1 partnering powered by Zühlke
11:00
Session 5 - Patient/user needs in development of combined products
Chair: Dorit Prüfer, Roche
​
Promoting patient safety through new supply chain controls under the medical device regulation (MDR) and the falsified medicines directive (FMD)
Barbara Polek, SFL
Impact of falsified medicines – the patient perspective
Jan Geissler, Patvocates
Human centered design - process design for usability
Raimund Erdmann, Erdmann Design
12:30
Break & 1-on-1 partnering powered by Zühlke
Afternoon
13:45
Session 6 - Value-based healthcare in the combined products field and patient engagement
Chair: Marie Picci, Novartis & David Haerry, European AIDS Treatment Group
​
Effectively engaging patients to support product development and post-market success
Dominique Hamerlijnck, EUPATI
Building Trusted AI in Healthcare
Andrew Koubatis, Altran
Rising to the challenge of VBR, and other healthcare trends, using ‘4D’ therapeutic systems
Alex Booth, Full Spectrum Innovation
15:15
Closing remarks
Shayesteh Fürst Ladani, SFL, President MPP Association
Sponsors
![]() | ![]() |
---|---|
![]() | ![]() |
![]() | ![]() |